PeptideStack
5.2kquestions
20kanswers
220users

What does STEP 1 tell me about dizziness at the 2 mg dose?

Asked 18 Aug 2025Modified 11 months agoViewed 11k times
30

Stated plainly: STEP 1 · dizziness · 2 mg.

I have read the primary source rather than the summary, which has left me with more questions.

I understand the headline. I do not understand the footnotes, and the footnotes look important.

What would I need in addition before this supported a decision?

clinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

745 questionstitration
titration

Stepwise dose increases over weeks, why the label schedules exist at all, and what tolerability-driven deviation from a schedule looks like in…

456 questions
shareeditfollowflag
BN
askedbridget_nyathi12k1518 Aug 2025
2Is that the primary endpoint or a secondary one? They get quoted interchangeably. – orla_sheridan 6 months ago
Do you have the population it was measured in? The figure moves a lot between them. – orla_ferriter 4 months ago
add a comment

No answers yet

This question has not been answered. It has been viewed 11k times, which suggests the question is of interest and the answer is not obvious. If you can answer it with a source or a worked calculation, it will be read. See how to ask and answer.
Sponsored

Sigma-Aldrich - Certified Reference Materials

Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.

Shop standards

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.